Physician profile
Dennise Ramirez
NPI 1134695141
$2,240.58
in general payments reported to CMS, 2019-2025
28 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $290 · 2022: $708 · 2023: $641 · 2024: $456 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $342.09 | 2023-2024 | Gemtesa, Orgovyx |
| Urovant Sciences INC | $301.38 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $238.80 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Olympus America INC. | $220.06 | 2021-2024 | Itind System |
| Abbvie INC. | $190.80 | 2022-2025 | |
| Coloplast Corp | $145.92 | 2023 | Speedicath |
| Tolmar Pharmaceuticals, INC. | $91.16 | 2021-2022 | |
| Tolmar, INC. | $73.17 | 2023-2024 | |
| 180 Medical, INC. | $70.47 | 2021-2023 | Gentlecath |
| Myovant Sciences INC. | $54.51 | 2021-2022 | |
| Boston Scientific Corporation | $51.59 | 2021 | |
| Acerus Pharmaceuticals Corporation | $50.67 | 2021-2022 | |
| Astellas Pharma US INC | $49.55 | 2023 | Veozah, Myrbetriq |
| Endo USA, INC. | $37.00 | 2024 | Xiaflex, Aveed |
| Baxter Healthcare | $33.80 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $32.59 | 2024 | Illuccix |
| Medtronic, INC. | $30.08 | 2022 | |
| Alnylam Pharmaceuticals INC. | $27.03 | 2023 | Givlaari |
| Blue Earth Diagnostics | $26.42 | 2021 | |
| Angiodynamics, INC. | $26.32 | 2022 | |
| Abc Home Medical Supply, INC. | $22.23 | 2024 | |
| Procept Biorobotics Corporation | $21.74 | 2024 | Aquabeam System |
| Hollister Incorporated | $19.13 | 2023 | Vapro |
| Convatec INC. | $18.95 | 2021 | |
| Teleflex LLC | $18.31 | 2023 | Urolift |
| Ferring Pharmaceuticals INC. | $17.48 | 2024 | Adstiladrin |
| Photocure INC | $15.48 | 2024 | Cysview |
| Sagent Pharmaceuticals | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennise Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.